WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer

Katharina Tiefenböck-Hansson,Aaro Haapaniemi,Lovisa Farnebo,Björn Palmgren,Jussi Tarkkanen,Marianne Farnebo,Eva Munck-Wikland,Antti Mäkitie,Stina Garvin,Karin Roberg

WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer

2017

Katharina Tiefenböck-Hansson
Aaro Haapaniemi
Lovisa Farnebo
Björn Palmgren
Jussi Tarkkanen
Marianne Farnebo
Eva Munck-Wikland
Antti Mäkitie
Stina Garvin
Karin Roberg

The current treatment recommendation for T2-3N0M0 glottic squamous cell carcinoma (SCC) in the Nordic countries comprises of radiotherapy (RT) and chemoradiotherapy (CRT). Tumor radiosensitivity va ...

Keywords:

Survivin
Molecular medicine
Glottic Squamous Cell Carcinoma
Cancer
Oncology
Oncogene
Radiation therapy
Radiosensitivity
Chemoradiotherapy
Medicine
Internal medicine
Laryngeal Neoplasm
Head and neck cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations